Literature DB >> 20727382

Interleukin-1β induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and C/EBPβ, AP-1, and NF-κB activation.

Tiziana Persichini1, Nunziata Maio, Maria Carmela Bonaccorsi di Patti, Gianluca Rizzo, Sarah Toscano, Marco Colasanti, Giovanni Musci.   

Abstract

Previously, we demonstrated that IL-1β was able to increase iron efflux from glial cells through a coordinate induction of both ferroportin-1 (Fpn) and ceruloplasmin (Cp) synthesis. In this study, we have investigated the signaling pathways that are involved in the transcriptional activation of the Cp and Fpn. Our data show that the expression of Cp and Fpn in response to IL-1β requires the activation of MAP kinase pathways as a consequence of an IL-1β receptor stimulation. Moreover, we have observed that IL-1β regulates the expression of Cp and Fpn genes through (i) p38 MAPK-mediated activation of C/EBP transcription factor, (ii) ERK1/2-, JNK1- and partially p38 MAPK-dependent activation of AP-1, and through (iii) activation of NF-κB partially mediated by p38 MAPK.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20727382     DOI: 10.1016/j.neulet.2010.08.034

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  16 in total

Review 1.  Ceruloplasmin-ferroportin system of iron traffic in vertebrates.

Authors:  Giovanni Musci; Fabio Polticelli; Maria Carmela Bonaccorsi di Patti
Journal:  World J Biol Chem       Date:  2014-05-26

Review 2.  The biology of mammalian multi-copper ferroxidases.

Authors:  Sheridan L Helman; Jie Zhou; Brie K Fuqua; Yan Lu; James F Collins; Huijun Chen; Christopher D Vulpe; Gregory J Anderson; David M Frazer
Journal:  Biometals       Date:  2022-02-15       Impact factor: 3.378

3.  Non-mutagenic Suppression of Enterocyte Ferroportin 1 by Chemical Ribosomal Inactivation via p38 Mitogen-activated Protein Kinase (MAPK)-mediated Regulation: EVIDENCE FOR ENVIRONMENTAL HEMOCHROMATOSIS.

Authors:  Chang-Kyu Oh; Seong-Hwan Park; Juil Kim; Yuseok Moon
Journal:  J Biol Chem       Date:  2016-07-21       Impact factor: 5.157

4.  Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.

Authors:  Ilambarthi Lokamani; Mee-Lee Looi; Siti Aishah Md Ali; Ahmad Zailani Hatta Mohd Dali; Muhammad Azrif Ahmad Annuar; Rahman Jamal
Journal:  Pathol Oncol Res       Date:  2013-08-08       Impact factor: 3.201

5.  Polymorphisms of interleukin-1 Beta and interleukin-17Alpha genes are associated with restless legs syndrome.

Authors:  Mary Dawn Hennessy; Rochelle S Zak; Caryl L Gay; Clive R Pullinger; Kathryn A Lee; Bradley E Aouizerat
Journal:  Biol Res Nurs       Date:  2013-03-03       Impact factor: 2.522

6.  Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling.

Authors:  Xiangsheng Xiao; Dingbo Shi; Liqun Liu; Jingshu Wang; Xiaoming Xie; Tiebang Kang; Wuguo Deng
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

Review 7.  Interaction between macrophages and ferroptosis.

Authors:  Yan Yang; Yu Wang; Lin Guo; Wen Gao; Ting-Li Tang; Miao Yan
Journal:  Cell Death Dis       Date:  2022-04-16       Impact factor: 9.685

8.  IL-1β-specific recruitment of GCN5 histone acetyltransferase induces the release of PAF1 from chromatin for the de-repression of inflammatory response genes.

Authors:  Nari Kim; Hwa-Young Sun; Min-Young Youn; Joo-Yeon Yoo
Journal:  Nucleic Acids Res       Date:  2013-03-14       Impact factor: 16.971

Review 9.  Mechanisms and regulation of iron trafficking across the capillary endothelial cells of the blood-brain barrier.

Authors:  Ryan C McCarthy; Daniel J Kosman
Journal:  Front Mol Neurosci       Date:  2015-07-14       Impact factor: 5.639

10.  Amyloid beta(1-40)-induced astrogliosis and the effect of genistein treatment in rat: a three-dimensional confocal morphometric and proteomic study.

Authors:  Maryam Bagheri; Arjang Rezakhani; Sofie Nyström; Maria V Turkina; Mehrdad Roghani; Per Hammarström; Simin Mohseni
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.